The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| BU | +0.78% | -93.61% | -42.32% | -86% |
| S&P | +16.9% | +95.99% | +14.39% | +448% |
Burcon NutraScience Corp. engages in the development of plant proteins and ingredients for use in the food and beverage industries in Canada. The firm's products include CLARISOY, a soy protein for dairy foods, neutral pH beverages, and coffee creamers and whiteners, and Peazazz, a pea protein for dairy alternative products, such as protein bars and crisps, weight management and meal replacement products, and vegetarian and vegan foods, as well as dry blended and ready-to-drink beverages. It also offers Supertein and Puratein, which are canola protein isolates for use in beverages, confectionery, aerated desserts, protein bars, baked goods, dressings, sauces, and meat substitutes. The company was founded on November 3, 1998 and is headquartered in Vancouver, Canada.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.34M | 44.6% |
| Gross Profit | -$1.95M | -1205.9% |
| Gross Margin | -568.51% | -505.6% |
| Market Cap | $50.88M | -88.2% |
| Market Cap / Employee | $3.39M | 0.0% |
| Employees | 15 | -40.0% |
| Net Income | -$3.48M | -85.9% |
| EBITDA | -$1.96M | -23.6% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $4.23M | 95.6% |
| Accounts Receivable | $0.54M | 31.8% |
| Inventory | 0.4 | 1092.6% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $18.96M | 189.5% |
| Short Term Debt | $3.31M | 46799.9% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -52.59% | 13.7% |
| Return On Invested Capital | -81.44% | -3.1% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$2.78M | -39.8% |
| Operating Free Cash Flow | -$2.63M | -45.1% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 111.15 | 166.67 | -3275.86 | 7.33 | -92.53% |
| Price to Sales | 84.66 | 33.70 | 48.88 | 104.48 | 43.98% |
| Price to Tangible Book Value | 173.59 | 688.66 | -202.75 | 8.94 | -93.10% |
| Enterprise Value to EBITDA | -14.44 | -11.07 | -19.56 | -35.08 | 59.61% |
| Return on Equity | -267.9% | -597.2% | -136.6% | -278.6% | 74.82% |
| Total Debt | $6.80M | $7.80M | $22.40M | $22.27M | 239.72% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
